Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

21.33
+0.11000.52%
Post-market: 21.20-0.1300-0.61%17:21 EDT
Volume:1.31M
Turnover:28.02M
Market Cap:2.65B
PE:-168.14
High:21.59
Open:21.50
Low:21.12
Close:21.22
52wk High:31.77
52wk Low:11.86
Shares:124.03M
Float Shares:88.24M
Volume Ratio:1.31
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1269
EPS(LYR):-0.1269
ROE:-9.30%
ROA:-1.95%
PB:13.96
PE(LYR):-168.14

Loading ...

Stock Track | Arcutis Biotherapeutics Soars 5.15% Intraday on Strong Earnings and Analyst Upgrades

Stock Track
·
Feb 27

Arcutis Biotherapeutics Is Maintained at Buy by Needham

Dow Jones
·
Feb 26

Stock Track | Arcutis Biotherapeutics Soars 5.78% in Pre-Market on Analyst Upgrades Following Strong Earnings

Stock Track
·
Feb 26

Arcutis Biotherapeutics, Inc. : H.c. Wainwright Raises Target Price to $34 From $30

THOMSON REUTERS
·
Feb 26

Arcutis Biotherapeutics Inc : TD Cowen Raises Target Price to $35 From $30

THOMSON REUTERS
·
Feb 26

Stock Track | Arcutis Biotherapeutics Soars 5.52% After-Hours on Strong Q4 Earnings Beat and Raised 2026 Guidance

Stock Track
·
Feb 26

Stock Track | Arcutis Biotherapeutics Soars 5.07% After-Hours on Strong Q4 Earnings Beat and Raised 2026 Guidance

Stock Track
·
Feb 26

Arcutis Biotherapeutics files automatic mixed securities shelf

TIPRANKS
·
Feb 26

BRIEF-Arcutis Biotherapeutics Inc Files For Mixed Shelf

Reuters
·
Feb 26

BRIEF-Arcutis Announces Fourth Quarter And Full Year 2025 Financial Results

Reuters
·
Feb 26

Arcutis Biotherapeutics Inc Files for Mixed Shelf; Size Not Disclosed- SEC Filing

THOMSON REUTERS
·
Feb 26

Arcutis Q4 revenue rises 84% on ZORYVE sales, raises FY guidance

Reuters
·
Feb 26

Arcutis Biotherapeutics Q4 EPS $0.13 Beats $0.10 Estimate, Sales $129.503M Beat $113.055M Estimate

Benzinga
·
Feb 26

Arcutis posts FY 2025 ZORYVE net product revenue of USD 372.1 million up 123%

Reuters
·
Feb 26

Arcutis Biotherapeutics Inc - Raises 2026 Sales Guidance to $480-$495 Mln

THOMSON REUTERS
·
Feb 26

Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
Feb 26

U.S. Earnings Preview: After Market Close Feb. 25

Dow Jones
·
Feb 26

Arcutis announces Max Homa joins ‘Free to Be Me’ campaign

TIPRANKS
·
Feb 24

Arcutis Biotherapeutics Grants 94,000 Restricted Stock Units to New Employees

Reuters
·
Feb 06

Press Release: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
Feb 06